SCHEMBL5483343

SCHEMBL5483343

COC(O)C(O)(OC)C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.37
KCNN4 O15554 1/20 0.36
ALDH1A1 P00352 3/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C19 P33261 2/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.32
TTR P02766 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
EDNRB P24530 3/20 0.31
EDNRA P25101 3/20 0.31
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
NR1I2 O75469 1/20 0.31
KCNE1 P15382 1/20 0.31
KCNQ1 P51787 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9068006 0.77 KIF11 (0.35) CES1KCNN4ALDH1A1ALOX15MAPK1
SCHEMBL10512565 0.75 CES1 (0.40) CES1KCNN4ALDH1A1ALOX15MAPK1
SCHEMBL10417502 0.74 KCNN4 (0.47) CES1KCNN4ALDH1A1ALOX15MAPK1
SCHEMBL5133753 0.71 CES1 (0.44) CES1KCNN4ALDH1A1ALOX15MAPK1
SCHEMBL5069848 0.71 KIF11 (0.38) CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL4372562 0.66 CES1 (0.47) CES1KCNN4ALDH1A1ALOX15MAPK1
SCHEMBL28117527 0.66 CES1 (0.47) CES1KCNN4ALDH1A1ALOX15MAPK1
SCHEMBL319709 0.66 CES1 (0.47) CES1KCNN4ALDH1A1ALOX15MAPK1
SCHEMBL20357349 0.66 ALDH1A1 (0.46) CES1KCNN4ALDH1A1ALOX15MAPK1
SCHEMBL20702253 0.66 ALDH1A1 (0.46) CES1KCNN4ALDH1A1ALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070117773-A1 Telomerase-inhibiting ENA oligonucleotide SANKYO COMPANY, LIMITED (JP) 2007-05-24 US disclosed
EP-1783216-A1 TELOMERASE-INHIBITORY ENA OLIGONUCLEOTIDE Sankyo Company, Limited (JP) 2007-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117773-A1 Telomerase-inhibiting ENA oligonucleotide TERT, ENO1, TERB1 CES1 3999/4885KCNN4 3006/4885ALDH1A1 2161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.